---
figid: PMC6289335__41401_2018_62_Fig1_HTML
figlink: /pmc/articles/PMC6289335/figure/Fig1/
number: F1
caption: Schematic diagram of the molecular actions of CTLA-4 and PD-1 on inhibiting
  T cell function. TCR binds to the antigen peptide presented by HLA class I and class
  II molecules to initiate cellular signaling. CD80 and CD86 expressed on antigen-presenting
  cells interact with CD28 on T cells, inducing the activation of the PI3K-Akt-mTOR
  pathway, which co-operates with the TCR signaling to activate the downstream Ras/MEK/Erk
  pathway for the full activation of T cells. a Once TCR signaling is initiated, intracellular
  CTLA-4 translocates to the cell surface and competes with CD28 for binding to CD80
  and CD86; phosphorylated CTLA-4 also recruits and activates phosphatases PP2A and
  SHP-2, which dephosphorylates PTEN and subsequently inactivates PI3K/Akt/mTOR signaling.
  b TCR signaling induces the upregulation of PD-1. The interaction of PD-1 with its
  ligands leads to the phosphorylation of PD-1, which recruits and activates SHP-2.
  Similar to the scenario for CTLA-4, PTEN is activated, and PI3K/Akt/mTOR signaling
  is inhibited. In addition, the activation of PD-1 impairs the activity of the Ras/MEK/Erk
  pathway
pmcid: PMC6289335
papertitle: Cancer immune checkpoint blockade therapy and its associated autoimmune
  cardiotoxicity.
reftext: Jiu-cheng Zhang, et al. Acta Pharmacol Sin. 2018 Nov;39(11):1693-1698.
pmc_ranked_result_index: '11515'
pathway_score: 0.8344686
filename: 41401_2018_62_Fig1_HTML.jpg
figtitle: Molecular actions of CTLA-4 and PD-1 on inhibiting T cell function
year: '2018'
organisms:
- Homo sapiens
ndex: 12607d32-de98-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6289335__41401_2018_62_Fig1_HTML.html
  '@type': Dataset
  description: Schematic diagram of the molecular actions of CTLA-4 and PD-1 on inhibiting
    T cell function. TCR binds to the antigen peptide presented by HLA class I and
    class II molecules to initiate cellular signaling. CD80 and CD86 expressed on
    antigen-presenting cells interact with CD28 on T cells, inducing the activation
    of the PI3K-Akt-mTOR pathway, which co-operates with the TCR signaling to activate
    the downstream Ras/MEK/Erk pathway for the full activation of T cells. a Once
    TCR signaling is initiated, intracellular CTLA-4 translocates to the cell surface
    and competes with CD28 for binding to CD80 and CD86; phosphorylated CTLA-4 also
    recruits and activates phosphatases PP2A and SHP-2, which dephosphorylates PTEN
    and subsequently inactivates PI3K/Akt/mTOR signaling. b TCR signaling induces
    the upregulation of PD-1. The interaction of PD-1 with its ligands leads to the
    phosphorylation of PD-1, which recruits and activates SHP-2. Similar to the scenario
    for CTLA-4, PTEN is activated, and PI3K/Akt/mTOR signaling is inhibited. In addition,
    the activation of PD-1 impairs the activity of the Ras/MEK/Erk pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - PDCD1
  - CD274
  - CTLA4
  - PIK3R3
  - CD28
  - AKT2
  - PIK3CG
  - NRAS
  - MAPK3
  - CD80
  - CD86
  - PIK3R5
  - PIK3R4
  - HRAS
  - PIK3CB
  - TRB
  - TRG
  - TRD
  - PPA2
  - PTEN
  - MTOR
  - PIK3R6
  - PIK3CA
  - PDCD1LG2
  - PIK3CD
  - MAP2K2
  - MAP2K1
  - PTPN11
  - AKT3
  - TRA
  - KRAS
  - MAPK1
  - HLA-II
  - Cancer
  - Lung cancer
genes:
- word: РІЗК/Akt/mTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PD-1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: PD-L1
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: CTLA-4
  symbol: CTLA4
  source: hgnc_symbol
  hgnc_symbol: CTLA4
  entrez: '1493'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: CD28
  symbol: CD28
  source: hgnc_symbol
  hgnc_symbol: CD28
  entrez: '940'
- word: РІЗК/Akt/mTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: Ras/MEK/Erk
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Ras/MEK/Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: CD80
  symbol: CD80
  source: hgnc_symbol
  hgnc_symbol: CD80
  entrez: '941'
- word: CD86
  symbol: CD86
  source: hgnc_symbol
  hgnc_symbol: CD86
  entrez: '942'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Ras/MEK/Erk
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
- word: PPA2
  symbol: PPA2
  source: hgnc_symbol
  hgnc_symbol: PPA2
  entrez: '27068'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: РІЗК/Akt/mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PD-L2
  symbol: PD-L2
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1LG2
  entrez: '80380'
- word: PI3K/Akt/MTOR
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Ras/MEK/Erk
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: Ras/MEK/Erk
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: SHP-2
  symbol: SHP-2
  source: hgnc_alias_symbol
  hgnc_symbol: PTPN11
  entrez: '5781'
- word: РІЗК/Akt/mTOR
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: Ras/MEK/Erk
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras/MEK/Erk
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
chemicals:
- word: HLA-II
  source: MESH
  identifier: D015234
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC6289335__F1
redirect_from: /figures/PMC6289335__F1
figtype: Figure
---
